With the widespread prevalence of chronic diseases, the growing population and the high per capita income of the people in the country, the pharma sector in Kuwait has a huge potential. Limited indigenous manufacturing capabilities also present several growth opportunities for foreign exporters.

Due to a wealthier consumer base of Kuwait, branded medicines used to dominate the pharma sector of the country for years. However, private health insurance schemes are encouraging prescribers to adopt more rational prescription patterns. This is likely to increase the demands for generic products in the coming years. Moreover, chronic diseases such as cardiovascular, diabetes, obesity, cancer and respiratory conditions are rising dramatically in Kuwait. This is primarily due to less physical activity and dietary habits such as increased fast food consumption. Thus, the market shares of anti-infective, gastrointestinal, cardiovascular and musculoskeletal are expected to increase rapidly in the coming years.

Under such circumstances, Neumedica Healthcare finds an opportunity to serve the indigenous population of Kuwait with its quality pharma products. Unlike typical Indian exporters who supply generics only, we supply a variety of branded medicines as well.

Our well researched branded medicines are gaining quick attention among folks along with our reputed generics. With a highly diversified product line across all healthcare categories, we are constantly expanding our business to reach sky-high limits.